^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    GENE:

    SH3PXD2A-AS1 (SH3PXD2A Antisense RNA 1)

    i
    Other names: SH3PXD2A-AS1, SH3PXD2A Antisense RNA 1, NONHSAG006784.2, HSALNG0080389, SH3PXD2A-AS1
    Associations

    News

    Trials
    over1year
    LncRNA SH3PXD2A-AS1 facilitates cisplatin resistance in non-small cell lung cancer by regulating FOXM1 succinylation. (PubMed, BMC Cancer)
    SH3PXD2A-AS1 promoted DDP resistance in NSCLC cells by regulating FOXM1 SUCC via SIRT7, offering a promising therapeutic approach for NSCLC.
    Journal
    |
    FOXM1 (Forkhead Box M1) • SH3PXD2A (SH3 And PX Domains 2A) • SH3PXD2A-AS1 (SH3PXD2A Antisense RNA 1) • SIRT7 (Sirtuin 7)
    |
    cisplatin
    over2years
    Construction of lncRNA-m6A gene-mRNA regulatory network to identify m6A-related lncRNAs associated with the progression of lung adenocarcinoma. (PubMed, BMC Pulm Med)
    These m6A target lncRNAs and mRNAs may be promising biomarkers for predicting clinical prognosis, and the lncRNA-m6A regulator-mRNA regulatory network could improve our understanding of m6A modification in LUAD progression.
    Journal
    |
    CCNA2 (Cyclin A2) • CDC25C (Cell Division Cycle 25C) • GNRP (Ras-Specific Guanine Nucleotide-Releasing Factor 1) • MAD2L1 (Mitotic Arrest Deficient 2 Like 1) • SH3PXD2A (SH3 And PX Domains 2A) • SH3PXD2A-AS1 (SH3PXD2A Antisense RNA 1)